Daniel M. Bendheim's most recent trade in Phibro Animal Health Corp. - Ordinary Shares - Class A was a trade of 300,000 Performance Stock Units done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp (Class A) | Daniel M. Bendheim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 300,000 | 300,000 | - | - | Performance Stock Units | |
| Phibro Animal Health Corp (Class A) | Daniel M. Bendheim | Director, Exec. VP, Corporate Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 3,964 | 3,964 (0%) | 0% | 0 | Class A Common Stock |